Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists

Drug Development Research

Volumn 9, Issue 2, 1986, Pages 85-93

  Ferkany, John W ^a   Valentine, Heather L ^a   Stone, George A ^b   Williams, Michael ^b  

^a Nova Pharmaceuticals   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

PACPX; 3H cyclohexyladenosine binding

Indexed keywords

1,3 DIETHYL 8 PHENYLXANTHINE; 2 CHLOROADENOSINE; 8 (2 AMINO 4 CHLOROPHENYL) 1,3 DIPROPYLXANTHINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; PHENYLISOPROPYLADENOSINE; RADIOISOTOPE; THEOPHYLLINE;

ANIMAL CELL; BRAIN; CATTLE; CENTRAL NERVOUS SYSTEM; COW; CYCLOHEXYLADENOSINE H 3; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFICACY; DRUG SENSITIVITY; GUINEA PIG; HUMAN; HUMAN CELL; MOUSE; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; RAT; TOPICAL DRUG ADMINISTRATION;

EID: 0022997406     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430090202     Document Type: Article

References (36)

1. Subclasses of adenosine receptor in brain membranes from adult tissue and from primary cultures of chick embryo
2. 3H]phenylxanthine
3. Adenosine receptor binding: structure activity analysis generated extremely potent xanthine antagonists
4. 3H]NECA to a subtype of A2 adenosine receptor in rat striatal membranes
5. 50) of an enzymatic reaction
6. Adenosine receptors: Target sites for drug
7. Adenosine receptors in the central nervous system: structure‐activity relationships for agonists and antagonists
8. Subclasses of adenosine receptors in the central nervous system: Interations with caffeine and related methylxanthines
9. 1,3 dialkyl‐8(p‐sulfophenyl)xanthines: potent water‐soluble antagonists for A1 and A2 adenosine receptors
10. Pyrazolo[3,4‐d]pyrimidines as adenosine antagonists
11. Potent and selective adenosine (A1) receptor antagonists
12. 3H]cyclohexyladenosine
13. Synthesis of xanthines as adenosine antagonists, a practical quantitative structure‐activity relationship application
14. Nomenclature of adenosine receptors
15. Interaction in the behavioral effects of methylxanthines and adenosine derivatives
16. The distributions of 5'nucleotidase and adenosine A1 receptors for diversification and conservation in the hippocampi of several commonly employed experimental animals
17. A new method to quantitate the interaction of slightly selective radioligands with multiple receptor subtypes
18. 6 Cycloalkyladenosines. Potent, A1 selective adenosine agonists
19. LIGAND: A versatile computerized approach for charcterization of ligand‐binding systems
20. Heterogeneity of adenosine A1 receptor binding in brain tissue
21. Comparison of the actions of several cariotonics on the cardiac cAMP‐phosphodiesterase in dog, ferret and guinea pig
22. The role of adenosine and its nucleotides in central synaptic transmission
23. The attractions of proteins for small molecules and ions
24. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
25. Summary of a symposium discussion on purine receptor nomenclature
26. Nitrobenzylthioinosine binding in brain: an interspecies study
27. Tissue and species differences in adenosine receptors: Their possible relationship to drug development
28. Adenosine (ado) receptors in the PC12 pheochromocytoma cell line: Characterization by radioligand binding
29. Evaluation of the binding of the A1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue
30. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15‐1788, with central adenosine receptors
31. 3H]cyclohexyladenosine: comparison with binding in neocortical membranes
32. Interaction of putative anxiolytic agents with central adenosine receptors